MOBILE VIEW  | 
Sort by

ADALIMUMAB

Detailed evidence-based information

ALEMTUZUMAB

Detailed evidence-based information

ALIROCUMAB

Detailed evidence-based information

ATEZOLIZUMAB

Detailed evidence-based information

BASILIXIMAB

Detailed evidence-based information

BELIMUMAB

Detailed evidence-based information

BEVACIZUMAB

Detailed evidence-based information

BEZLOTOXUMAB

Detailed evidence-based information

CANAKINUMAB

Detailed evidence-based information

CATUMAXOMAB

Detailed evidence-based information

CETUXIMAB

Detailed evidence-based information

DACLIZUMAB

Detailed evidence-based information

DARATUMUMAB

Detailed evidence-based information

DENOSUMAB

Detailed evidence-based information

DINUTUXIMAB

Detailed evidence-based information

ECULIZUMAB

Detailed evidence-based information

EDRECOLOMAB

Detailed evidence-based information

EFALIZUMAB

Detailed evidence-based information

ELOTUZUMAB

Detailed evidence-based information

EVOLOCUMAB

Detailed evidence-based information

FANOLESOMAB

Detailed evidence-based information

GOLIMUMAB

Detailed evidence-based information

IBRITUMOMAB TIUXETAN

Detailed evidence-based information

INFLIXIMAB

Detailed evidence-based information

INOLIMOMAB

Detailed evidence-based information

IPILIMUMAB

Detailed evidence-based information

IXEKIZUMAB

Detailed evidence-based information

MEPOLIZUMAB

Detailed evidence-based information

MUROMONAB-CD3

Detailed evidence-based information

NATALIZUMAB

Detailed evidence-based information

NEBACUMAB

Detailed evidence-based information

NECITUMUMAB

Detailed evidence-based information

NIVOLUMAB

Detailed evidence-based information

OBILTOXAXIMAB

Detailed evidence-based information

OBINUTUZUMAB

Detailed evidence-based information

OFATUMUMAB

Detailed evidence-based information

OLARATUMAB

Detailed evidence-based information

OMALIZUMAB

Detailed evidence-based information

OREGOVOMAB

Detailed evidence-based information

PALIVIZUMAB

Detailed evidence-based information

PANITUMUMAB

Detailed evidence-based information

PEMBROLIZUMAB

Detailed evidence-based information

PERTUZUMAB

Detailed evidence-based information

RAMUCIRUMAB

Detailed evidence-based information

RAXIBACUMAB

Detailed evidence-based information

RESLIZUMAB

Detailed evidence-based information

RITUXIMAB

Detailed evidence-based information

SATUMOMAB PENDETIDE

Detailed evidence-based information

SECUKINUMAB

Detailed evidence-based information

SILTUXIMAB

Detailed evidence-based information
1 2 Next